Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
20–45
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Healthy Japanese and Caucasian male subjects 20 to 45 years of age inclusive
Body weight between 50 and 85 kg, inclusive, with a Body Mass Index (BMI) ≥19 to ≤ 27 kg/m2
You may not be if
Clinically significant illness, surgical procedure or trauma, within two weeks preceding the pre-entry visit until first administration of IP, as judged by the investigator
History of clinically significant gastrointestinal, mental, cardiac, renal or hepatic disorder, or other significant disease as judged by the investigator
Habitual smoker (daily use) of tobacco or daily use of nicotine-containing products
Clareo Health | AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects
